首页> 外国专利> Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules

Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules

机译:通过将整联蛋白alphav beta3拮抗剂与免疫调节剂,抗炎剂,TNF-α拮抗剂或CD2结合分子一起给药来预防或治疗炎症或自身免疫性疾病的方法

摘要

As synergistic composition comprises an intergrin alphaVbeta3 antagonist, which is an antibody that immunospecifically binds to intergrin alphaVbeta3, and either a small organic molecule, which is a immunomodulatory agent or a T cell or cytokine receptor modulator, a non-steroidal anti-inflammatory drug, or a peptide, such as endostatin, angiostatin, apomigren, prolcatin and fibronectin. The compositions are useful for the treatment of inflammatory and autoimmune disorders.
机译:由于协同组合物包含整合素αVbeta3拮抗剂(是一种与整合素αVbeta3免疫特异性结合的抗体)和一个小的有机分子(一种免疫调节剂或T细胞或细胞因子受体调节剂),一种非甾体类抗炎药,或肽,例如内皮抑素,血管抑素,阿扑米仑,催乳素和纤连蛋白。该组合物可用于治疗炎性和自身免疫性疾病。

著录项

  • 公开/公告号NZ528076A

    专利类型

  • 公开/公告日2005-09-30

    原文格式PDF

  • 申请/专利权人 MEDIMMUNE INC;

    申请/专利号NZ20020528076

  • 发明设计人 DINGIVAN CHRISTINE;WILDER RONALD;

    申请日2002-03-04

  • 分类号A61K39/395;C07K16/28;A61P29/00;A61P37/00;

  • 国家 NZ

  • 入库时间 2022-08-21 22:16:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号